The majority of MMPs and TIMPs were mainly expressed in cancer cells at the invasive front (MMP-9: 97.3% of the tumors, MMP-11: 98.7%, MMP-14: 94.0%, TIMP-1: 86.7%, TIMP-2: 96.7%). This evidence concerns the gene TIMP2 and cancer.